Australia's Wesfarmers shares slide as high living costs temper second-half start | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]An employee of Bunnings, which is part of the Wesfarmers retail conglomerate, walks down an aisle at a store in Sydney, Australia February 17, 2022. REUTERS/Stephen Coates [Purchase Licensing Rights, opens new tab]- Companies- Summary- Interim dividend lifted to 102 Australian cents- Bunnings, Kmart, Wes ...

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e., buying assets at a discount, e.g., net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e., buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions, and wide moat compounders). Sign up here to get s ...

Key Takeaways Itron Q4 EPS of $2.46 beat estimates; revenues of $572M topped guidance despite 7% decline.Itron launched Resiliency Solutions after Urbint, Locusview deals; sees $65-$70M 2026 revenues.ITRI gross margin rose to 40.7% as bookings hit $737M; backlog reached $4.5B.Itron Inc. (ITRI) reported non-GAAP earnings per share (EPS) of $2.46 for fourth-quarter 2025, which beat the Zacks Consensus Estimate by 12.3%. The company reported earnings of $1.35 per share in the prior-year quarter. The uptick ref ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: TD Cowen upgraded Medpace (MEDP) to Hold from Sell with a price target of $419, down from $462. The shares have re-rated from a peak multiple and now reflect fair value, the firm tells investors in a research note.Citizens upgraded Rush Street Interactive (RSI) to Outperform from Market Perform with a $24 price ta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-22418 Itron, Inc. (Exact name of registrant as specified in its charter) Washington 91-1011792 (State of Incorporation) (I.R.S. Employer Identif ...

Starting the shortened trading week on a positive note, Itron (NASDAQ: ITRI) stock is soaring today. The technology company that provides meters and sensors for smart cities reported fourth-quarter 2025 financial results before the bell rang this morning, and investors are clearly impressed. As of 12:49 p.m. ET, Itron shares are up 8.7%, retreating from an earlier 17% gain. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensa ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Small-cap stocks showed marginal gains in Q4 2025, with the Russell 2000 Growth Index returning 13.01% and the Russell 2000 Value Index gaining 12.58% [1] - The investment management company anticipates a favorable year ahead for equity markets, highlighting potential opportunities in Cyclicals, Healthcare, Information Technology, Financials, and Consumer spending sectors for 2026 [1] Company-Specific Insights - Itron, Inc. (NASDAQ:ITRI) was identified as a major performance detractor, with a one-month return of -10.68% and a 12-month decline of 7.88%, closing at $89.36 per share on February 13, 2026 [2] - Itron, Inc. has a market capitalization of approximately $4.093 billion [2] - The company's stock performance was pressured due to softer than anticipated bookings, attributed to a temporary shift in utility customer priorities amid planning uncertainty and increased regulatory scrutiny [3] - Itron, Inc. is not among the 30 most popular stocks among hedge funds, with 37 hedge fund portfolios holding its shares at the end of Q3, up from 35 in the previous quarter [4]

For the quarter ended December 2025, Itron (ITRI) reported revenue of $571.66 million, down 6.7% over the same period last year. EPS came in at $2.46, compared to $1.35 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $561.79 million, representing a surprise of +1.76%. The company delivered an EPS surprise of +12.55%, with the consensus EPS estimate being $2.19.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...